Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines Journal:Investigational New Drugs | 2013 | ||
FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells Journal:Cancer Letters | 2011 | ||
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer Journal:Proceedings of the National Academy of Sciences | 2014 |